Endothelin-A Receptor Antagonism Retards the Progression of Murine Sickle Cell Nephropathy.

about

Endothelin-A Receptor Antagonism Retards the Progression of Murine Sickle Cell Nephropathy.

Item

http://www.wikidata.org/entity/Q52775082

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Endothelin-A Receptor Antagoni ...... urine Sickle Cell Nephropathy.

@en

Endothelin-A Receptor Antagoni ...... urine Sickle Cell Nephropathy.

@nl

type

Item

label

Endothelin-A Receptor Antagoni ...... urine Sickle Cell Nephropathy.

@en

Endothelin-A Receptor Antagoni ...... urine Sickle Cell Nephropathy.

@nl

prefLabel

Endothelin-A Receptor Antagoni ...... urine Sickle Cell Nephropathy.

@en

Endothelin-A Receptor Antagoni ...... urine Sickle Cell Nephropathy.

@nl

P1476

Endothelin-A Receptor Antagoni ...... urine Sickle Cell Nephropathy.

@en

P2093

Karl A Nath

http://www.w3.org/2001/XMLSchema#string

Zvonimir S Katusic

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease

Error and attack tolerance of complex networks

Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.

High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension

Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factor

Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture.

The perfusion paradox and vascular instability in sickle cell disease.

Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia.

Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha.

P304

2253-2255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1681/ASN.2017030320

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28442492

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

5533247

http://www.w3.org/2001/XMLSchema#string